Security
Ainos, Inc. Common Stock · AIMD
AIMDNASDAQCommon stockCurrentCIK 1014763Updated Oct 6, 2026
Name history
Ainos, Inc. · through Sep 28, 2026AMARILLO BIOSCIENCES INC · through Mar 30, 2021
AIMD price & chart
Loading TradingView…
NASDAQ:AIMD on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
424B5 filing
Changes in Registrant's Certifying Accountant
Items 4.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 20,871,108Source | 28,820,199Source | 31,841,804Source | 37,109,014Source |
| Property, Plant and Equipment, NetUSD | 343,281Source | 559,645Source | 876,572Source | 1,375,676Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 19,226,003Source | 23,748,328Source | 28,283,208Source | 32,806,738Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 417,353Source | 3,892,919Source | 1,885,628Source | 1,853,362Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 22Source | 56Source | 455Source | 201,546Source |
| Inventory, NetUSD | 295,565Source | 143,756Source | 167,593Source | 595,222Source |
| Assets, CurrentUSD | 1,138,799Source | 4,337,808Source | 2,473,197Source | 2,845,917Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | — | 419,521Source | — |
| Other Assets, NoncurrentUSD | 163,025Source | 174,418Source | 208,827Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 13,308,526Source | 13,303,889Source | 7,394,223Source | 2,481,008Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 69,827Source | 154,274Source | 46,778Source | 200,116Source |
| Additional Paid in CapitalUSD | 77,234,374Source | 68,520,881Source | 62,555,808Source | 58,745,149Source |
| Retained Earnings (Accumulated Deficit)USD | -67,520,328Source | -52,749,316Source | -37,886,155Source | -24,115,606Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -249,291Source | -409,529Source | -270,473Source | — |
| Stockholders' Equity Attributable to ParentUSD | 7,562,582Source | 15,516,310Source | 24,447,581Source | 34,628,006Source |
| Liabilities and EquityUSD | 20,871,108Source | 28,820,199Source | 31,841,804Source | 37,109,014Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,078,683Source | 3,954,944Source | 1,336,838Source | 2,472,912Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | 8,096Source |
| Other Liabilities, NoncurrentUSD | 1,229,843Source | 348,945Source | 135,829Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 14,006,690Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,728,055Source | 3,543,101Source | 1,114,767Source | 6,421,879Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -34Source | -399Source | -201,091Source | 201,546Source |
| Increase (Decrease) in InventoriesUSD | 151,809Source | -23,837Source | -221,767Source | 595,222Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | 2,837,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -4,614,697Source | -5,808,267Source | -4,694,668Source | -3,021,183Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,223Source | -125,292Source | -101,525Source | -630,178Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 34,561Source | 21,331Source | 92,984Source | 633,823Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,008,461Source | 8,025,746Source | 4,923,673Source | 3,831,245Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -3,475,566Source | 2,007,291Source | 32,266Source | 101,863Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 417,353Source | 3,892,919Source | 1,885,628Source | 1,853,362Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 32Source | 21,671Source | 16,897Source | 43,254Source |
| Income Taxes Paid, NetUSD | 800Source | 800Source | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,728,055Source | 3,543,101Source | 1,114,767Source | — |
| Amortization of Intangible AssetsUSD | 4,522,407Source | 4,534,729Source | — | 4,522,002Source |
| DepreciationUSD | 243,027Source | 252,548Source | 328,938Source | 291,706Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | 275,624Source | -94,207Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 1,096Source | — | -286,777Source | 0Source |
| Goodwill, Impairment LossUSD | — | — | 286,777Source | — |
| Income Tax Expense (Benefit)USD | 800Source | 800Source | 800Source | 0Source |
| InterestExpenseNonoperatingUSD | 711,903Source | 616,467Source | — | — |
| Inventory Write-downUSD | — | — | 235,047Source | — |
| Net Income (Loss) Attributable to ParentUSD | -14,771,012Source | -14,863,161Source | -13,770,549Source | -14,006,690Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -14,771,012Source | -14,863,161Source | — | — |
| Nonoperating Income (Expense)USD | -779,804Source | -1,021,157Source | -563,353Source | -30,478Source |
| Operating ExpensesUSD | 14,093,319Source | 13,809,338Source | 12,952,663Source | 15,381,555Source |
| Other Nonoperating Income (Expense)USD | -67,901Source | — | — | 23,050Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 0Source |
| Unrealized Gain (Loss) on DerivativesUSD | — | -275,624Source | 94,207Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 124,157Source | 20,729Source | 122,112Source | 3,519,627Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 6,343,547Source | 5,395,415Source | 5,635,275Source | 8,535,591Source |
| Operating Income (Loss)USD | -13,990,408Source | -13,841,204Source | -13,206,396Source | -13,976,212Source |
| Other Nonoperating Income (Expense)USD | -67,901Source | — | — | 23,050Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -14,770,212Source | -14,862,361Source | -13,769,749Source | — |
| Income Tax Expense (Benefit)USD | 800Source | 800Source | 800Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -14,771,012Source | -14,863,161Source | -13,770,549Source | -14,006,690Source |
| Earnings Per Share, BasicUSD per share | -3.46Source | -1.56Source | — | — |
| Earnings Per Share, DilutedUSD per share | -3.46Source | -1.56Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 4,270,815Source | 9,503,618Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 4,270,815Source | 9,503,618Source | — | — |
| Interest Expense (non-operating)USD | 711,903Source | 616,467Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 4,522,407Source | 4,534,729Source | — | 4,522,002Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 4,780,150Source | 4,801,716Source | 4,871,057Source | 4,833,428Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | 275,624Source | -94,207Source | — |
| Goodwill, Impairment LossUSD | — | — | 286,777Source | — |
| Gross ProfitUSD | 102,911Source | -31,866Source | -253,733Source | 1,405,343Source |
| Interest ExpenseUSD | — | — | 144,193Source | 53,528Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -14,771,012Source | -14,863,161Source | — | — |
| Nonoperating Income (Expense)USD | -779,804Source | -1,021,157Source | -563,353Source | -30,478Source |
| Operating ExpensesUSD | 14,093,319Source | 13,809,338Source | 12,952,663Source | 15,381,555Source |
| Other IncomeUSD | — | — | 12,276Source | — |
| Research and Development ExpenseUSD | 7,749,772Source | 8,413,923Source | 7,317,388Source | 6,845,964Source |
Filing attachments
ex99-1.htm · 8-K · 2026-09-28
Exhibit 99.1 Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approval Partner assumes assigned clinical and regulatory funding and execution, reducing Ainos’ independent capital and staffing requirements Ainos retains existing platform ownership and 25% of applicable net sublicensing r…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-03
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced results for the second quarter ended June 30, 2026, and provided a business update on continued execution progress for AI Nose across semiconductor manufacturing, industrial infrastructure, robotics, and healthcare-rel…
Read attachment ↗ex99-1.htm · 8-K · 2026-05-13
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets HOUSTON, TX / ACCESS Newswire / May 13, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) (“Ainos” or the “Company”) today announced financial results for the first quarter ended March 31, 2026 and provided a business update on recent execution progress for AI Nose across semiconductors and healthcare infrastructure…
Read attachment ↗ex4-7.htm · 10-K · 2026-03-30
EXHIBIT 4.7 DESCRIPTION OF SECURITIES Ainos, Inc. (the “Company,” “we,” “us” or “our”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.01 per share, and warrants to purchase common stock (the “Warrants”). General Our authorized capital stock consists of 300,000,000 shares of common stock, par value $0.01 per share, and 50,000,000 shares of preferred stock, par value $0.01 per sha…
Read attachment ↗ex99-1.htm · 8-K · 2026-03-30
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026 AI Nose drove 499% revenue growth in 2025, with gross margin turning positive to 82.9% 2025 partnerships now driving scaled AI Nose deployments in 2026, supported by disciplined financing HOUSTON, TX / ACCESS Newswire / March 30, 2026 / Ainos, Inc. (NASDAQ: AIMD)(NASDAQ: AIMDW) (“Ainos” or the “Company”) today reported financial results for the year en…
Read attachment ↗ex107.htm · S-8 · 2026-02-13
Exhibit 107 Calculation of Filing Fee Table Form S-8 Ainos Inc. (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities Security Security Fee Calculation Amount Proposed Maximum Fee Rate Amount of Rule Registered(1) Maximum Offering Aggregate …
Read attachment ↗